Internal Medicine · Fresno, CA
NPI
1487633764
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
3120 Tulare St, #102
Fresno, CA, 93721
Phone (559) 233-0933
Groups this clinician bills Medicare through
Medicare paid, 2024
$179K
2,923 services
Medicare patients, 2024
238
Average age 73
Drug cost, 2024
$3.0M
16,093 prescriptions
Company payments, 2025
$1,522
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ajit S Khaira was code 99214 (office e&m - established), 893 times for 231 patients. In total Ajit S Khaira billed 2,923 services in 25 codes, and Medicare paid $179K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-02-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 893 | 231 | $103.71 | $93K |
| 82962 Clinical Chemistry | Office | 759 | 133 | $3.21 | $2,436 |
| 99213 Office E&M - Established | Office | 440 | 174 | $71.08 | $31K |
| 99212 Office E&M - Established | Office | 195 | 75 | $46.56 | $9,078 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 159 | 159 | $142.78 | $23K |
| G0008 Administration of influenza virus vaccine | Office | 140 | 140 | $32.91 | $4,607 |
| 90661 Vaccine Product | Office | 140 | 140 | $36.11 | $5,055 |
| 93000 Electrocardiogram | Office | 29 | 24 | $11.70 | $339 |
| G0180 Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 26 | 22 | $47.35 | $1,231 |
| 90732 Vaccine Product | Office | 19 | 19 | $130.80 | $2,485 |
| G0009 Administration of pneumococcal vaccine | Office | 19 | 19 | $32.91 | $625 |
| G0402 Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 12 | 12 | $181.29 | $2,175 |
By year: 2022 $168K for 3,160 services; 2023 $173K for 3,195 services; 2024 $179K for 2,923 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82962 Clinical Chemistry | 759 | 133 | $3.21 | $2,436 |
Medicare prescription drug claims, 2024
In 2024, the drug Ajit S Khaira prescribed most often to Medicare patients was Atorvastatin Calcium, with 1,231 prescriptions and refills. In total Ajit S Khaira wrote 16,093 Medicare prescriptions that cost $3.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 1,231 | 3,051 | 309 | $12K |
| Amlodipine Besylate Generic | 1,212 | 3,124 | 330 | $6,798 |
| Valsartan Generic | 1,004 | 2,551 | 257 | $30K |
| Metoprolol Succinate Generic | 830 | 1,948 | 208 | $13K |
| Metformin Hcl Generic | 627 | 1,484 | 160 | $4,432 |
| Ezetimibe Generic | 577 | 1,458 | 162 | $23K |
| Jardiance Empagliflozin | 490 | 1,085 | 113 | $583K |
| Fluticasone Propionate Generic | 463 | 836 | 147 | $5,733 |
| Naproxen Generic | 447 | 473 | 151 | $9,310 |
| Pioglitazone Hcl Generic | 439 | 1,172 | 120 | $6,468 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 382 | 383 | 62 | $7,518 |
| Rosuvastatin Calcium Generic | 348 | 892 | 95 | $8,560 |
| Levothyroxine Sodium Generic | 309 | 694 | 66 | $3,699 |
| Vascepa Icosapent Ethyl | 308 | 601 | 82 | $215K |
| Famotidine Generic | 295 | 497 | 74 | $2,383 |
Brand drugs: 2,970 claims; generic drugs: 13,059 claims; opioid claims: 617.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ajit S Khaira $1,522 ($1,522 in general payments such as food, travel and fees) from 11 companies. The largest payer was Novo Nordisk Inc with $330.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 22 | $330 |
| Amgen Inc. AMGN | 16 | $325 |
| AstraZeneca Pharmaceuticals LP AZN | 11 | $238 |
| Novartis Pharmaceuticals Corporation NVS | 15 | $193 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 3 | $175 |
| GlaxoSmithKline, LLC. GSK | 6 | $104 |
| Abbvie Inc. ABBV | 3 | $61.88 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $41.72 |
| Sumitomo Pharma America, Inc. 4506.T | 2 | $30.43 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 1 | $22.81 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.